AnalystsFaisal KhurshidFaisal Khurshid's Stock Forecasts
AnalystsFaisal Khurshid
Sectors:
Analyst Ranking
Bottom 10%
#4401 out of 4862 analysts
Average Return
-27.84%
Win Rate
21%3 out of 14
Risk vs Reward
Poor
Good
Faisal Khurshid's 5 best and worst ratings
Faisal Khurshid Analyst Color
Get additional color on Faisal Khurshid's coverage of popular stocks
Faisal Khurshid's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Ironwood Pharmaceuticals IncIRWD | 2 | Hold | $1.00 | +41.84% | Maintains | 8 days ago |
Spyre Therapeutics IncSYRE | 1 | Buy | $45.00 | +231.61% | Initiates Coverage On | 15 days ago |
Nurix Therapeutics IncNRIX | 1 | Hold | $16.00 | +51.66% | Initiates Coverage On | a month ago |
Shattuck Labs IncSTTK | 1 | Buy | $4.00 | +409.55% | Initiates Coverage On | a month ago |
Pliant Therapeutics IncPLRX | 2 | Hold | $2.00 | +35.14% | Downgrades | 2 months ago |
Atyr Pharma IncATYR | 1 | Buy | $16.00 | +387.80% | Initiates Coverage On | 2 months ago |
Kymera Therapeutics IncKYMR | 2 | Buy | $60.00 | +120.91% | Maintains | 4 months ago |
Ani Pharmaceuticals IncANIP | 1 | Buy | $80.00 | +17.65% | Initiates Coverage On | 4 months ago |
Zura Bio LtdZURA | 1 | Buy | $15.00 | +994.89% | Initiates Coverage On | 6 months ago |
Trevi Therapeutics IncTRVI | 1 | Buy | $7.00 | +16.28% | Assumes | 7 months ago |
Puretech Health PLCPRTC | 1 | Buy | $45.00 | +168.82% | Assumes | 7 months ago |
Galapagos NvGLPG | 1 | Hold | $24.00 | -2.60% | Initiates Coverage On | 7 months ago |
Geron CorpGERN | 1 | Buy | $7.00 | +418.52% | Initiates Coverage On | 7 months ago |
Mannkind CorpMNKD | 1 | Buy | $8.00 | +80.18% | Assumes | 7 months ago |
Immunic IncIMUX | 1 | Buy | $5.00 | +405.56% | Assumes | 7 months ago |
Fusion Pharmaceuticals IncFUSN | 1 | Hold | $21.00 | N/A | Downgrades | a year ago |
Rain Oncology IncRAIN2 | 1 | Buy | $11.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.